首页> 外国专利> METHOD FOR STABILIZING BLOOD PRESSURE DURING BLOOD DIALYSIS

METHOD FOR STABILIZING BLOOD PRESSURE DURING BLOOD DIALYSIS

机译:血液透析过程中稳定血压的方法

摘要

PROBLEM TO BE SOLVED: To provide use of a phosphodiestelase(PDE) inhibitor in the manufacture of a medicament to stabilize blood pressure during hemodialysis. SOLUTION: A phosphodiestelase(PDE) inhibitor in the manufacture of a medicament to stabilize blood pressure during hemodialysis using phosphodiestelase(PDE) is preferably cGMP PDE inhibitor. One preferred cGMP PDEv inhibitor is sildenafil or a pharmaceutically acceptable salt. The PDE inhibitor compound can be administered in any conventional oral, parenteral, rectal or transdermal dosage form, usually also together with a pharmaceutically acceptable vehicle, diluent or carrier. Accordingly, the PDE inhibitor compound described above (including formulation or composition containing the PDE inhibitor described herein) may be used in the manufacture of a medicament for the therapeutic applications described in this specification.
机译:要解决的问题:提供磷酸二酯酶(PDE)抑制剂在药物生产中的用途,以稳定血液透析期间的血压。解决方案:在使用磷酸二酯酶(PDE)进行血液透析过程中稳定血压的药物制造中,磷酸二酯酶(PDE)抑制剂优选为cGMP PDE抑制剂。一种优选的cGMP PDEv抑制剂是西地那非或药学上可接受的盐。 PDE抑制剂化合物可以任何常规的口服,肠胃外,直肠或透皮剂型给药,通常还与药学上可接受的载体,稀释剂或载体一起给药。因此,上述PDE抑制剂化合物(包括含有本文所述的PDE抑制剂的制剂或组合物)可用于制备用于本说明书中描述的治疗用途的药物。

著录项

  • 公开/公告号JP2001354589A

    专利类型

  • 公开/公告日2001-12-25

    原文格式PDF

  • 申请/专利权人 PFIZER PROD INC;

    申请/专利号JP20010124462

  • 发明设计人 ERIC BEN GROSSMAN;

    申请日2001-04-23

  • 分类号A61K45/00;A61K31/522;A61K31/5377;A61P9/02;A61P43/00;

  • 国家 JP

  • 入库时间 2022-08-22 00:54:16

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号